Our hope was to verify if we could demonstrate an early-predictor of CRC recurrences and propose an optimal time, prior to the start of adjuvant treatments, to analyze the methylation of the SEPT9 gene. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.